Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Post-Market Assessment Of NanOss Bioactive 3D in the Posterolateral Spine

NCT01829997 is registered in ClinicalTrials.gov with Pioneer Surgical Technology, Inc. as lead sponsor.

NCT NCT01829997
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01829997 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Post-Market Assessment Of NanOss Bioactive 3D in the Posterolateral Spine
Lead sponsor
Pioneer Surgical Technology, Inc.
Phase
Not applicable
Overall status
Completed
Start date
April 30, 2013
Completion date
April 30, 2018
Enrollment
22 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

degenerative disc disease, spinal stenosis, spondylolisthesis